Onboarding flows also make a difference
Somatostatin receptor distribution A large number of studies have sought to characterize the expression of SSTs in human pancreatic tissues, but cataloging the differences between them is beyond the scope of this review (6, 12, 27, 28)
Zhang, J., et al., Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management
Barnett MJL et al
Before making any changes to your GLP-1 medication management, consider these factors: Current treatment response: If your injectable medication is working well, switching may not offer additional benefits Lifestyle compatibility: The empty stomach requirement and 30-minute waiting period requires consistent daily scheduling Cost considerations: Insurance coverage for the pill may differ from injectable coverage initially Other medications: The timing restrictions may complicate existing medication schedules Optimizing Your Results: Beyond the Medication Whether you choose oral or injectable GLP-1 treatment, medication alone isnt the complete picture